期刊
HELIYON
卷 8, 期 3, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.heliyon.2022.e0903
关键词
Colorectal cancer; Autophagy; HSPB8; 5-Fluorouracil resistance; Colorectal cancer; Autophagy; HSPB8; 5-Fluorouracil resistance
资金
- National Nature Science Foundation of China [81903034]
- development of Nanjing medical science and technology foundation [YKK17123]
HSPB8 plays a significant role in CRC 5-FU resistance by acting together with its co-chaperone BAG3 in autophagy-driven resistance. Additionally, the expression level of HSPB8 is significantly correlated with immune cell infiltration.
The emergence of 5-Fluorouracil (5-FU) resistance is the barrier to effective clinical outcomes for colorectal cancer (CRC) patients. Autophagy was found to be involved in protecting tumor cells from 5-FU. However, the specific role of autophagy-related genes in CRC 5-FU resistance remains unclear. In this study, HSPB8 among 34 differentially expressed ARGs in CRC was identified to be the hub ARGs in 5-FU resistant which was downregulated in CRC samples when compared with normal samples but up-regulated in CRC samples with relatively higher lymphatic invasion, later stages and poor prognosis of CRC. Mechanistic analysis demonstrated that due to the recruitment of CAFs, HSPB8 expression was enhanced in CRC cells so that HSPB8 could act together with its co-chaperone BAG3 in autophagy drived 5-FU resistance. Furthermore, the augmented expression level of HSPB8 was found to be significantly correlated to the immune cell infiltration such as Treg cells, macrophages, monocyte and dendritic cells and so on. Our results suggested CAFs driving HSPB8 induced CRC 5-FU resistance by promoting tumor autophagy would provide a new strategy in seeking potential CRC therapeutic target.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据